Global Overactive Bladder Treatment Industry Market Analysis & Forecast 2018-2023

Name: Global Overactive Bladder Treatment Industry Market Analysis & Forecast 2018-2023
Brand: S&P Consulting
SKU: G5178A9F2F6EN
Price: 3040 USD
Availability: InStock

July 2018 | 104 pages | ID: G5178A9F2F6EN
S&P Consulting

US$ 3,040.00 ~~US$ 3,800.00~~ -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In the Global Overactive Bladder Treatment Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

Global Overactive Bladder Treatment Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Astellas Pharma, Inc. (Japan)
Pfizer, Inc. (U.S.)
Allergan, Plc. (Ireland)
Teva Pharmaceutical Industries Limited (Israel)
Mylan N.V. (U.S.)
Medtronic plc (Ireland)
Endo International plc (Ireland)
Sanofi (France)
Hisamitsu Pharmaceutical Co., Inc. (Japan)

Global Overactive Bladder Treatment Market: Product Segment Analysis
Idiopathic
Neurogenic Bladder Overactivity
Type 3

Global Overactive Bladder Treatment Market: Application Segment Analysis
Hospital
Clinic
Others

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Global Overactive Bladder Treatment Industry Market Analysis & Forecast 2018-2023

CHAPTER 1 OVERACTIVE BLADDER TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Overactive Bladder Treatment
1.2 Overactive Bladder Treatment Market Segmentation by Type in 2016
  1.2.1 Global Production Market Share of Overactive Bladder Treatment by Type in 2016
  1.2.1 Idiopathic
  1.2.2 Neurogenic Bladder Overactivity
  1.2.3 Type
1.3 Overactive Bladder Treatment Market Segmentation by Application in 2016
  1.3.1 Overactive Bladder Treatment Consumption Market Share by Application in 2016
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Overactive Bladder Treatment Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Overactive Bladder Treatment (2013-2023)
  1.5.1 Global Product Sales and Growth Rate (2013-2023)
  1.5.2 Global Product Revenue and Growth Rate (2013-2023)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON OVERACTIVE BLADDER TREATMENT INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL OVERACTIVE BLADDER TREATMENT MARKET COMPETITION BY MANUFACTURERS

3.1 Global Overactive Bladder Treatment Production and Share by Manufacturers (2016 and 2017)
3.2 Global Overactive Bladder Treatment Revenue and Share by Manufacturers (2016 and 2017)
3.3 Global Overactive Bladder Treatment Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Overactive Bladder Treatment Manufacturing Base Distribution, Production Area and Product Type
3.5 Overactive Bladder Treatment Market Competitive Situation and Trends
  3.5.1 Overactive Bladder Treatment Market Concentration Rate
  3.5.2 Overactive Bladder Treatment Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL OVERACTIVE BLADDER TREATMENT PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

4.1 Global Overactive Bladder Treatment Production by Region (2013-2018)
4.2 Global Overactive Bladder Treatment Production Market Share by Region (2013-2018)
4.3 Global Overactive Bladder Treatment Revenue (Value) and Market Share by Region (2013-2018)
4.4 Global Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
4.5 North America Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
  4.5.1 North America Overactive Bladder Treatment Production and Market Share by Manufacturers
  4.5.2 North America Overactive Bladder Treatment Production and Market Share by Type
  4.5.3 North America Overactive Bladder Treatment Production and Market Share by Application
4.6 Europe Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
  4.6.1 Europe Overactive Bladder Treatment Production and Market Share by Manufacturers
  4.6.2 Europe Overactive Bladder Treatment Production and Market Share by Type
  4.6.3 Europe Overactive Bladder Treatment Production and Market Share by Application
4.7 China Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
  4.7.1 China Overactive Bladder Treatment Production and Market Share by Manufacturers
  4.7.2 China Overactive Bladder Treatment Production and Market Share by Type
  4.7.3 China Overactive Bladder Treatment Production and Market Share by Application
4.8 Japan Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
  4.8.1 Japan Overactive Bladder Treatment Production and Market Share by Manufacturers
  4.8.2 Japan Overactive Bladder Treatment Production and Market Share by Type
  4.8.3 Japan Overactive Bladder Treatment Production and Market Share by Application
4.9 Southeast Asia Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
  4.9.1 Southeast Asia Overactive Bladder Treatment Production and Market Share by Manufacturers
  4.9.2 Southeast Asia Overactive Bladder Treatment Production and Market Share by Type
  4.9.3 Southeast Asia Overactive Bladder Treatment Production and Market Share by Application
4.10 India Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
  4.10.1 India Overactive Bladder Treatment Production and Market Share by Manufacturers
  4.10.2 India Overactive Bladder Treatment Production and Market Share by Type
  4.10.3 India Overactive Bladder Treatment Production and Market Share by Application

CHAPTER 5 GLOBAL OVERACTIVE BLADDER TREATMENT SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2013-2018)

5.1 Global Overactive Bladder Treatment Consumption by Regions (2013-2018)
5.2 North America Overactive Bladder Treatment Production, Consumption, Export, Import by Regions (2013-2018)
5.3 Europe Overactive Bladder Treatment Production, Consumption, Export, Import by Regions (2013-2018)
5.4 China Overactive Bladder Treatment Production, Consumption, Export, Import by Regions (2013-2018)
5.5 Japan Overactive Bladder Treatment Production, Consumption, Export, Import by Regions (2013-2018)
5.6 Southeast Asia Overactive Bladder Treatment Production, Consumption, Export, Import by Regions (2013-2018)
5.7 India Overactive Bladder Treatment Production, Consumption, Export, Import by Regions (2013-2018)

CHAPTER 6 GLOBAL OVERACTIVE BLADDER TREATMENT PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Overactive Bladder Treatment Production and Market Share by Type (2013-2018)
6.2 Global Overactive Bladder Treatment Revenue and Market Share by Type (2013-2018)
6.3 Global Overactive Bladder Treatment Price by Type (2013-2018)
6.4 Global Overactive Bladder Treatment Production Growth by Type (2013-2018)

CHAPTER 7 GLOBAL OVERACTIVE BLADDER TREATMENT MARKET ANALYSIS BY APPLICATION

7.1 Global Overactive Bladder Treatment Consumption and Market Share by Application (2013-2018)
7.2 Global Overactive Bladder Treatment Revenue and Market Share by Type (2013-2018)
7.3 Global Overactive Bladder Treatment Consumption Growth Rate by Application (2013-2018)
7.4 Market Drivers and Opportunities
  7.4.1 Potential Applications
  7.4.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL OVERACTIVE BLADDER TREATMENT MANUFACTURERS ANALYSIS

8.1 Astellas Pharma, Inc. (Japan)
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.1.4 Business Overview
8.2 Pfizer, Inc. (U.S.)
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.2.4 Business Overview
8.3 Allergan, Plc. (Ireland)
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.3.4 Business Overview
8.4 Teva Pharmaceutical Industries Limited (Israel)
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.4.4 Business Overview
8.5 Mylan N.V. (U.S.)
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.5.4 Business Overview
8.6 Medtronic plc (Ireland)
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.6.4 Business Overview
8.7 Endo International plc (Ireland)
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.7.4 Business Overview
8.8 Sanofi (France)
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.8.4 Business Overview
8.9 Hisamitsu Pharmaceutical Co., Inc. (Japan)
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.9.4 Business Overview
…

CHAPTER 9 OVERACTIVE BLADDER TREATMENT MANUFACTURING COST ANALYSIS

9.1 Overactive Bladder Treatment Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Overactive Bladder Treatment

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Overactive Bladder Treatment Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Overactive Bladder Treatment Major Manufacturers in 2016
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL OVERACTIVE BLADDER TREATMENT MARKET FORECAST (2018-2023)

13.1 Global Overactive Bladder Treatment Production, Revenue Forecast (2018-2023)
13.2 Global Overactive Bladder Treatment Production, Consumption Forecast by Regions (2018-2023)
13.3 Global Overactive Bladder Treatment Production Forecast by Type (2018-2023)
13.4 Global Overactive Bladder Treatment Consumption Forecast by Application (2018-2023)
13.5 Overactive Bladder Treatment Price Forecast (2018-2023)

CHAPTER 14 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Overactive Bladder Treatment
Figure Global Production Market Share of Overactive Bladder Treatment by Neurogenic Bladder Overactivity016
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Overactive Bladder Treatment Consumption Market Share by Application in 2016
Figure Hospital Examples
Figure Clinic Examples
Figure Others Examples
Figure North America Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure China Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Japan Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Southeast Asia Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure India Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Overactive Bladder Treatment Revenue (Million UDS) and Growth Rate (2013-2023)
Table Global Overactive Bladder Treatment Capacity of Key Manufacturers (2016 and 2017)
Table Global Overactive Bladder Treatment Capacity Market Share by Manufacturers (2016 and 2017)
Figure Global Overactive Bladder Treatment Capacity of Key Manufacturers in 2016
Figure Global Overactive Bladder Treatment Capacity of Key Manufacturers in 2017
Table Global Overactive Bladder Treatment Production of Key Manufacturers (2016 and 2017)
Table Global Overactive Bladder Treatment Production Share by Manufacturers (2016 and 2017)
Figure 2015 Overactive Bladder Treatment Production Share by Manufacturers
Figure 2016 Overactive Bladder Treatment Production Share by Manufacturers
Table Global Overactive Bladder Treatment Revenue (Million USD) by Manufacturers (2016 and 2017)
Table Global Overactive Bladder Treatment Revenue Share by Manufacturers (2016 and 2017)
Table 2015 Global Overactive Bladder Treatment Revenue Share by Manufacturers
Table 2016 Global Overactive Bladder Treatment Revenue Share by Manufacturers
Table Global Market Overactive Bladder Treatment Average Price of Key Manufacturers (2016 and 2017)
Figure Global Market Overactive Bladder Treatment Average Price of Key Manufacturers in 2016
Table Manufacturers Overactive Bladder Treatment Manufacturing Base Distribution and Sales Area
Table Manufacturers Overactive Bladder Treatment Product Type
Figure Overactive Bladder Treatment Market Share of Top 3 Manufacturers
Figure Overactive Bladder Treatment Market Share of Top 5 Manufacturers
Table Global Overactive Bladder Treatment Capacity by Regions (2013-2018)
Figure Global Overactive Bladder Treatment Capacity Market Share by Regions (2013-2018)
Figure Global Overactive Bladder Treatment Capacity Market Share by Regions (2013-2018)
Figure 2015 Global Overactive Bladder Treatment Capacity Market Share by Regions
Table Global Overactive Bladder Treatment Production by Regions (2013-2018)
Figure Global Overactive Bladder Treatment Production and Market Share by Regions (2013-2018)
Figure Global Overactive Bladder Treatment Production Market Share by Regions (2013-2018)
Figure 2015 Global Overactive Bladder Treatment Production Market Share by Regions
Table Global Overactive Bladder Treatment Revenue by Regions (2013-2018)
Table Global Overactive Bladder Treatment Revenue Market Share by Regions (2013-2018)
Table 2015 Global Overactive Bladder Treatment Revenue Market Share by Regions
Table Global Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table North America Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Europe Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table China Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Japan Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Southeast Asia Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table India Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Global Overactive Bladder Treatment Consumption Market by Regions (2013-2018)
Table Global Overactive Bladder Treatment Consumption Market Share by Regions (2013-2018)
Figure Global Overactive Bladder Treatment Consumption Market Share by Regions (2013-2018)
Figure 2015 Global Overactive Bladder Treatment Consumption Market Share by Regions
Table North America Overactive Bladder Treatment Production, Consumption, Import & Export (2013-2018)
Table Europe Overactive Bladder Treatment Production, Consumption, Import & Export (2013-2018)
Table China Overactive Bladder Treatment Production, Consumption, Import & Export (2013-2018)
Table Japan Overactive Bladder Treatment Production, Consumption, Import & Export (2013-2018)
Table Southeast Asia Overactive Bladder Treatment Production, Consumption, Import & Export (2013-2018)
Table India Overactive Bladder Treatment Production, Consumption, Import & Export (2013-2018)
Table Global Overactive Bladder Treatment Production by Type (2013-2018)
Table Global Overactive Bladder Treatment Production Share by Type (2013-2018)
Figure Production Market Share of Overactive Bladder Treatment by Type (2013-2018)
Figure 2015 Production Market Share of Overactive Bladder Treatment by Type
Table Global Overactive Bladder Treatment Revenue by Type (2013-2018)
Table Global Overactive Bladder Treatment Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Overactive Bladder Treatment by Type (2013-2018)
Figure 2015 Revenue Market Share of Overactive Bladder Treatment by Type
Table Global Overactive Bladder Treatment Price by Type (2013-2018)
Figure Global Overactive Bladder Treatment Production Growth by Type (2013-2018)
Table Global Overactive Bladder Treatment Consumption by Application (2013-2018)
Table Global Overactive Bladder Treatment Consumption Market Share by Application (2013-2018)
Figure Global Overactive Bladder Treatment Consumption Market Share by Application in 2016
Table Global Overactive Bladder Treatment Consumption Growth Rate by Application (2013-2018)
Figure Global Overactive Bladder Treatment Consumption Growth Rate by Application (2013-2018)
Table Astellas Pharma, Inc. (Japan) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Astellas Pharma, Inc. (Japan) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Astellas Pharma, Inc. (Japan) Overactive Bladder Treatment Market Share (2013-2018)
Table Pfizer, Inc. (U.S.) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer, Inc. (U.S.) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Pfizer, Inc. (U.S.) Overactive Bladder Treatment Market Share (2013-2018)
Table Allergan, Plc. (Ireland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Allergan, Plc. (Ireland) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Allergan, Plc. (Ireland) Overactive Bladder Treatment Market Share (2013-2018)
Table Teva Pharmaceutical Industries Limited (Israel) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Teva Pharmaceutical Industries Limited (Israel) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Teva Pharmaceutical Industries Limited (Israel) Overactive Bladder Treatment Market Share (2013-2018)
Table Mylan N.V. (U.S.) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mylan N.V. (U.S.) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Mylan N.V. (U.S.) Overactive Bladder Treatment Market Share (2013-2018)
Table Medtronic plc (Ireland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Medtronic plc (Ireland) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Medtronic plc (Ireland) Overactive Bladder Treatment Market Share (2013-2018)
Table Endo International plc (Ireland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Endo International plc (Ireland) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Endo International plc (Ireland) Overactive Bladder Treatment Market Share (2013-2018)
Table Sanofi (France) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi (France) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Sanofi (France) Overactive Bladder Treatment Market Share (2013-2018)
Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2013-2018)
Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Overactive Bladder Treatment Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Overactive Bladder Treatment
Figure Manufacturing Process Analysis of Overactive Bladder Treatment
Figure Overactive Bladder Treatment Industrial Chain Analysis
Table Raw Materials Sources of Overactive Bladder Treatment Major Manufacturers in 2016
Table Major Buyers of Overactive Bladder Treatment
Table Distributors/Traders List
Figure Global Overactive Bladder Treatment Production and Growth Rate Forecast (2018-2023)
Figure Global Overactive Bladder Treatment Revenue and Growth Rate Forecast (2018-2023)
Table Global Overactive Bladder Treatment Production Forecast by Regions (2018-2023)
Table Global Overactive Bladder Treatment Consumption Forecast by Regions (2018-2023)
Table Global Overactive Bladder Treatment Production Forecast by Type (2018-2023)
Table Global Overactive Bladder Treatment Consumption Forecast by Application (2018-2023)

COMPANIES MENTIONED

Astellas Pharma, Inc. (Japan) Pfizer, Inc. (U.S.) Allergan, Plc. (Ireland) Teva Pharmaceutical Industries Limited (Israel) Mylan N.V. (U.S.) Medtronic plc (Ireland) Endo International plc (Ireland) Sanofi (France) Hisamitsu Pharmaceutical Co., Inc. (Japan)

Global Overactive Bladder Treatment Industry Market Analysis & Forecast 2018-2023

More Publications

Need Help?

Ask a Question

Market Reports